Home › Research › Getting a diagnosis
Economic burden of Alzheimer disease and managed care considerations
Wong W.. The American journal of managed care, 2020-08-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Alzheimer disease is the most common cause of dementia and the fifth leading cause of death in adults older than 65 years. The estimated total healthcare costs for the treatment of Alzheimer disease in 2020 is estimated at $305 billion, with the cost expected to increase to more than $1 trillion as the population ages. Most of the direct costs of care for Alzheimer disease are attributed to skilled nursing care, home healthcare, and hospice care. Indirect costs of care, including quality of life and informal caregiving, are likely underestimated and are associated with significant negative societal and personal burden. Managed care organizations are in a unique position to develop utilization strategies that would positively impact early diagnosis and treatment to lead to better outcomes and lower costs for patients, caregivers, and the healthcare system. Additionally, the recent inclusion of Alzheimer disease diagnoses into risk corridor calculations by the Centers for Medicare & Medicaid Services may encourage Medicare Advantage organizations to invest in programs that aid in its early detection and diagnosis.
What this study adds
Evidence grade: Low
This paper describes the large and growing financial cost of Alzheimer's disease care, much of it from skilled nursing, home health, and hospice services, with indirect costs likely underestimated. It suggests that managed care organizations could use strategies focused on early diagnosis and treatment to improve outcomes and lower costs.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wong, W. (2020). Economic burden of Alzheimer disease and managed care considerations. The American journal of managed care. https://doi.org/10.37765/ajmc.2020.88482
Vancouver
Wong W. Economic burden of Alzheimer disease and managed care considerations. The American journal of managed care. 2020. doi:10.37765/ajmc.2020.88482. PMID: 32840331.
BibTeX
@article{wong2020-32840331,
author = {Wong, W.},
title = {{Economic burden of Alzheimer disease and managed care considerations}},
journal = {The American journal of managed care},
year = {2020},
doi = {10.37765/ajmc.2020.88482},
pmid = {32840331},
url = {https://doi.org/10.37765/ajmc.2020.88482}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Indirect costs of care, including quality of life and informal caregiving, are likely underestimated and are associated with significant negative societal and personal burden.
Why it matters
This paper describes the large and growing financial cost of Alzheimer's disease care, much of it from skilled nursing, home health, and hospice services, with indirect costs likely underestimated. It suggests that managed care organizations could use strategies focused on early diagnosis and treatment to improve outcomes and lower costs.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Evidence strengthLow
How this study scored 47/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record and institution's track record, so those were left out: it earned 44 of the 93 points we could judge it on, which is 47 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (The American journal of managed care) |
| Journal's citation record | 0 / 4 | The American Journal of Managed Care: journal h-index 38 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 401 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 50.1 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 5 / 6 | Cited 35.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 12 other studies in this library |
| Still being cited | 3 / 4 | Cited 180 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32840331) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 44 / 93 | Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 44 of the 93 points we could judge it on is 47 out of 100. |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.37765/ajmc.2020.88482
- PubMed: 32840331
- Original source →
- Free full text: The American Journal of Managed Care →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 33.
Later studies that cite this one
11 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Getting a diagnosis from nearby years
Also in Getting a diagnosis
141 studies in the library are filed under Getting a diagnosis with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Getting a diagnosis hub.